Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS · Delayed Price · Currency is USD
0.0856
+0.0059 (7.40%)
Aug 26, 2025, 1:27 PM EDT
Enzon Pharmaceuticals Market Cap
Enzon Pharmaceuticals has a market cap or net worth of $5.91 million as of August 26, 2025. Its market cap has decreased by -48.28% in one year.
Market Cap
5.91M
Enterprise Value
5.17M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since January 16, 1990, Enzon Pharmaceuticals's market cap has decreased from 108.08M to 5.91M, a decrease of -94.53%. That is a compound annual growth rate of -7.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 25, 2025 | 5.91M | -48.94% |
Dec 31, 2024 | 11.58M | 66.86% |
Dec 29, 2023 | 6.94M | -62.07% |
Dec 30, 2022 | 18.31M | -27.99% |
Dec 31, 2021 | 25.42M | 37.89% |
Dec 31, 2020 | 18.43M | 102.39% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nika Pharmaceuticals | 972.93M |
Veradigm | 823.67M |
Tian'an Technology Group | 682.77M |
Glass House Brands | 636.43M |
Elite Pharmaceuticals | 594.22M |
CytoDyn | 388.66M |
Northwest Biotherapeutics | 357.21M |
American Oncology Network | 357.05M |